New guidelines for endocrine diseases released

Canine and feline endocrinopathies reflect an endocrine gland disease or dysfunction with resulting hormonal abnormali- ties that can variably affect the patient’s wellbeing, quality of life, and life expectancy. These guidelines provide consensus recommendations for diagnosis and treatment of four canine and feline endocrinopathies commonly encountered in clini- cal practice: canine hypothyroidism, canine hypercortisolism (Cushing’s syndrome), canine hypoadrenocorticism (Addi son’s disease), and feline hyperthyroidism.

To aid the general practitioner in navigating these common diseases, a stepwise diagnosis and treatment algorithm and relevant background information is provided for managing each of these diseases. The guidelines also describe, in lesser detail, the diagnosis and treatment of three relatively less common endo- crinopathies of cats: feline hyperaldosteronism, feline hypothyroidism, and feline hyperadrenocorticism. Additionally, the guidelines present tips on effective veterinary team utilization and client communication when discussing endocrine cases.

Read the guidelines by clicking on the link below:

2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines